SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
淡定语柔
Lv3
350 积分
2023-04-04 加入
最近求助
最近应助
互助留言
Statistical considerations for some issues in clinical bridging studies evaluating companion diagnostic devices
2个月前
已完结
Statistical considerations for some issues in clinical bridging studies evaluating companion diagnostic devices
6个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
6个月前
已完结
Mirvetuximab Soravtansine: First Approval
9个月前
已完结
Assessment of the Diagnostic Accuracy of Laboratory Tests Using Receiver Operating Characteristic Curves; Approved Guideline-Second Edition
10个月前
已关闭
Efficacy and Safety of the Anti–PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study
11个月前
已完结
Comment on ‘statistical consideration and challenges in bridging study of personalized medicine’: a modified variance for sensitivity analysis
11个月前
已完结
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study
1年前
已完结
Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study
1年前
已完结
Antibody drug conjugates: The dos and don'ts in clinical development
1年前
已完结
没有进行任何应助
感谢
2个月前
感谢
6个月前
帮大忙了
6个月前
不需要了【积分已退回】
10个月前
感谢
11个月前
感谢
11个月前
感谢
1年前
速度真快
1年前
感谢
1年前
速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论